Helian is an independent company focusing on consumer health. It was listed on the New York Stock Exchange on July 20th, 2022, but its own strength has not reached the level of the world's top 500, so it is not the world's top 500. Helion's brand portfolio includes Carch, Shancun, Shushida, Fenbid, Voltalin, New Contac, Baiduobang, flixonase, Baolijing and so on.